The pharmaceutical company is planning an IPO, but the timing is uncertain. Clearly, their internal system is heading in that direction.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The pharmaceutical company is planning an IPO, but the timing is uncertain. Clearly, their internal system is heading in that direction.